User profiles for P. Klenerman
paul klenermanUniversity of Oxford Verified email at ndm.ox.ac.uk Cited by 86701 |
T cells and viral persistence: lessons from diverse infections
P Klenerman, A Hill - Nature immunology, 2005 - nature.com
Persistent virus infections create specific problems for their hosts. Although the dynamics of
immune responses after acute infection are well studied and very consistent, especially in …
immune responses after acute infection are well studied and very consistent, especially in …
T cell responses to cytomegalovirus
P Klenerman, A Oxenius - Nature Reviews Immunology, 2016 - nature.com
Human cytomegalovirus (HCMV) establishes a latent infection that generally remains
asymptomatic in immune-competent hosts for decades but can cause serious illness in immune-…
asymptomatic in immune-competent hosts for decades but can cause serious illness in immune-…
MAIT cells in health and disease
NM Provine, P Klenerman - Annual review of immunology, 2020 - annualreviews.org
Mucosal-associated invariant T (MAIT) cells have been attracting increasing attention over
the last few years as a potent unconventional T cell subset. Three factors largely account for …
the last few years as a potent unconventional T cell subset. Three factors largely account for …
Analysis of successful immune responses in persons infected with hepatitis C virus
…, G Robbins, R Phillips, P Klenerman… - The Journal of …, 2000 - rupress.org
Although hepatitis C virus (HCV) infection is very common, identification of patients during
acute infection is rare. Consequently, little is known about the immune response during this …
acute infection is rare. Consequently, little is known about the immune response during this …
Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes
P Klenerman, RM Zinkernagel - Nature, 1998 - nature.com
Some viruses, including human immunodeficiency virus (HIV) and hepatitis B virus (HBV) in
humans, and lymphocytic choriomeningitis virus (LCMV) in mice, are initially controlled by …
humans, and lymphocytic choriomeningitis virus (LCMV) in mice, are initially controlled by …
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
…, RJ Cornall, CP Conlon, P Klenerman… - Nature …, 2020 - nature.com
The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines
and therapeutics will depend on understanding viral immunity. We studied T cell memory …
and therapeutics will depend on understanding viral immunity. We studied T cell memory …
MAIT cells are activated during human viral infections
…, CB Willberg, GR Screaton, P Klenerman - Nature …, 2016 - nature.com
Mucosal-associated invariant T (MAIT) cells are abundant in humans and recognize
bacterial ligands. Here, we demonstrate that MAIT cells are also activated during human viral …
bacterial ligands. Here, we demonstrate that MAIT cells are also activated during human viral …
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
… -fold (p < 0.0001) compared with Victoria and 3.6-fold (p < 0.0001… -fold (p < 0.0001) compared
with Victoria and 3.6-fold (p < … 2.7-fold (p < 0.0001) and 34.2fold (p < 0.0001) following the …
with Victoria and 3.6-fold (p < … 2.7-fold (p < 0.0001) and 34.2fold (p < 0.0001) following the …
Genetic mechanisms of critical illness in COVID-19
Host-mediated lung inflammation is present 1 , and drives mortality 2 , in the critical illness
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Functional impairment of T cells is characteristic of many chronic mouse and human viral
infections. The inhibitory receptor programmed death 1 (PD-1; also known as PDCD1), a …
infections. The inhibitory receptor programmed death 1 (PD-1; also known as PDCD1), a …